Results 171 to 180 of about 836,306 (300)
About improvement of system of measures of traffic safety
Kairat A. Bakishev, B. M. Nurgaliev
openalex +1 more source
Cycling traffic at turbo roundabouts: some considerations related to cyclist mobility and safety
Tiziana Campisi +5 more
openalex +1 more source
Bioorthogonal SDPTAC harnesses US‐responsive Ce6‐TCO and Tz ligands via IEDDA click chemistry to assemble degraders in situ, generating ROS that selectively eliminate nuclear, cytosolic, and membrane proteins, thereby suppressing deep‐seated tumors in vivo.
Yuhan Bao +8 more
wiley +1 more source
Road Traffic Safety in Developing Countries: Taking China as an Example. [PDF]
Zhang S.
europepmc +1 more source
This work introduces a study that identifies HMGCR as a novel target in TNBC and develops a light‐gated PROTAC nanomedicine. Upon irradiation, this agent selectively degrades HMGCR, reprogramming lipid metabolism to induce ferroptosis and potent antitumor immunity, thereby significantly enhancing photoimmunotherapy efficacy.
Tong Su +18 more
wiley +1 more source
PERSIAN traffic safety and health cohort: a population-based precrash cohort study. [PDF]
Golestani M +15 more
europepmc +1 more source
Engineered CAR‐NKT Extracellular Vesicles Suppress Tumor Progression and Enhance Antitumor Immunity
TM4SF1‐nanobody engineered CAR‐natural killer T–derived extracellular vesicles (CARTM4SF1‐EVs) provide a cell‐free alternative to CAR‐NKT therapy, achieving potent, targeted antitumor activity with reduced toxicity. CARTM4SF1‐EVs induce immunogenic cell death, remodel the tumor microenvironment, and enhance CD8⁺ T‐cell antitumor immunity.
Xiaopei Hao +14 more
wiley +1 more source

